Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SNPS | Common Stock | Sale | -$3.88M | -12.3K | -6.97% | $314.98 | 165K | Aug 20, 2021 | Direct | F1, F2 |
transaction | SNPS | Common Stock | Options Exercise | $9.71M | +161K | +97.8% | $60.37 | 325K | Aug 20, 2021 | Direct | |
transaction | SNPS | Common Stock | Sale | -$50.7M | -161K | -49.44% | $314.98 | 165K | Aug 20, 2021 | Direct | F2 |
transaction | SNPS | Common Stock | Options Exercise | $9.54M | +105K | +64.08% | $90.51 | 270K | Aug 20, 2021 | Direct | |
transaction | SNPS | Common Stock | Sale | -$33.2M | -105K | -39.05% | $314.98 | 165K | Aug 20, 2021 | Direct | F2 |
transaction | SNPS | Common Stock | Options Exercise | $28.1K | +310 | +0.19% | $90.51 | 165K | Aug 23, 2021 | Direct | |
transaction | SNPS | Common Stock | Sale | -$98.1K | -310 | -0.19% | $316.43 | 165K | Aug 23, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SNPS | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -161K | -100% | $0.00* | 0 | Aug 20, 2021 | Common Stock | 161K | $60.37 | Direct | F1 |
transaction | SNPS | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -105K | -87.24% | $0.00 | 15.4K | Aug 20, 2021 | Common Stock | 105K | $90.51 | Direct | F1, F3 |
transaction | SNPS | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -310 | -2.01% | $0.00 | 15.1K | Aug 23, 2021 | Common Stock | 310 | $90.51 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
F2 | Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $310.62 to $317.55. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. |
F3 | 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |